What is Epigene Labs?
Epigene Labs catalyzes the integration of genomics into oncology R&D decision-making. Thanks to its user-friendly interface, our technology platform enables cancer drug hunters to leverage state-of-the-art AI in the exploration of exponentially increasing amounts of genomic data – spanning multiple public and private databases, cancer types, and molecular layers. We develop this platform through value-based partnerships with leading cancer centers and biotech companies in Europe and in the US.
Business and value proposition
Epigene allows smart aggregation of genomic data for drug discovery in oncology.
The company aims to build a fully integrated genomics database (core database) as well as a seamless interface (drug discovery applications) for the analysis of genomic data powered by advanced biostatistics, artificial intelligence, and system biology methods.
%20Florian%20Lehmann%2C%20Flavio%20Alario%2C%20Kenan%20Deniz.jpg)
